255 related articles for article (PubMed ID: 7886617)
1. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
Torcharus K; Withayathawornwong W; Sriphaisal T; Krutvacho T; Arnutti P; Suwanasophorn C
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():96-9. PubMed ID: 7886617
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
Tripatara A; Jetsrisuparb A; Teeratakulpisarn J; Kuaha K
Thromb Res; 2007; 120(6):805-10. PubMed ID: 17382994
[TBL] [Abstract][Full Text] [Related]
3. Morphological assessment of platelet activation in thalassemia.
Bunyaratvej A; Komanasin N; Sriurairatana S; Fucharoen S
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():60-4. PubMed ID: 1298995
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic risk of children with thalassemia.
Chuansumrit A; Hathirat P; Isarangkura P; Pintadit P; Mahaphan W
J Med Assoc Thai; 1993 Oct; 76 Suppl 2():80-4. PubMed ID: 7823010
[TBL] [Abstract][Full Text] [Related]
5. [Oromaxillofacial changes in thalassemia major].
De Mattia D; Pettini PL; Sabato V; Rubini G; Laforgia A; Schettini F
Minerva Pediatr; 1996; 48(1-2):11-20. PubMed ID: 9072660
[TBL] [Abstract][Full Text] [Related]
6. Desferrioxamine induced urinary iron excretion in thalassemia.
Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of platelets from red cell fragments using laser technology: comparison between splenectomized and nonsplenectomized thalassemic patients.
Bunyaratvej A
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():250-2. PubMed ID: 7886588
[TBL] [Abstract][Full Text] [Related]
8. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic alterations in beta-thalassemia/hemoglobin E patients.
Opartkiattikul N; Tatsumi N; Funahara Y; Shirahata A; Wongtiraporn W; Tientadakul P; Fucharoen S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():86-9. PubMed ID: 10926266
[TBL] [Abstract][Full Text] [Related]
10. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening.
Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
Ann Hematol; 2004 Jul; 83(7):430-3. PubMed ID: 14722738
[TBL] [Abstract][Full Text] [Related]
12. Splenectomy for children with thalassemia.
Al-Salem AH; Nasserulla Z
Int Surg; 2002; 87(4):269-73. PubMed ID: 12575813
[TBL] [Abstract][Full Text] [Related]
13. Brain pathology in 6 fatal cases of post-transfusion hypertension, convulsion and cerebral hemorrhage syndrome.
Sonakul D; Fucharoen S
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():116-9. PubMed ID: 1298984
[TBL] [Abstract][Full Text] [Related]
14. Serum erythropoietin levels in pediatric patients with beta-thalassemia/hemoglobin E.
Paritpokee N; Wiwanitkit V; Bhokaisawan N; Boonchalermvichian C; Preechakas P
Clin Lab; 2002; 48(11-12):631-4. PubMed ID: 12465748
[TBL] [Abstract][Full Text] [Related]
15. [Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].
Cario H; Stahnke K; Kohne E
Klin Padiatr; 1999; 211(6):431-7. PubMed ID: 10592921
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous platelet aggregation in thalassemic children and adolescents.
Laosombat V; Wongchanchailert M; Kenpitak K; Wisitpongpon C
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():42-6. PubMed ID: 1298992
[TBL] [Abstract][Full Text] [Related]
17. Protein C and protein S deficiency in thalassemic patients.
Shirahata A; Funahara Y; Opartkiattikul N; Fucharoen S; Laosombat V; Yamada K
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():65-73. PubMed ID: 1298996
[TBL] [Abstract][Full Text] [Related]
18. Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients.
Viprakasit V; Kankirawatana S; Akarasereenont P; Durongpisitkul K; Chotewuttakorn S; Tanphaichitr VS
Am J Hematol; 2002 Jul; 70(3):260-2. PubMed ID: 12118430
[TBL] [Abstract][Full Text] [Related]
19. Thrombin activatable fibrinolysis inhibitor (TAFI): relationship to hemostatic alteration in patients with beta-thalassemia.
Mokhtar GM; Matter RM; Shawki H; Abdel Aziz MM
Pediatr Hematol Oncol; 2010 Aug; 27(5):363-73. PubMed ID: 20670166
[TBL] [Abstract][Full Text] [Related]
20. Hb E beta +-thalassaemia in west Malaysia: clinical features in the most common beta-thalassaemia mutation of the Malays [IVS 1-5 (G-->C)].
George E; Wong HB
Singapore Med J; 1993 Dec; 34(6):500-3. PubMed ID: 8153710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
